Huiyu Pharmaceutical (688553.SH): Injection Carfizomib Obtained Drug Registration Certificate.

19:34 13/03/2026

Huiyu Pharmaceuticals (688553.SH) released an announcement, stating that the company recently received the drug registration certificate for their company product, Carfilzomib for Injection, approved and issued by the National Medical Products Administration. Carfilzomib for Injection is primarily used for the treatment of multiple myeloma.

Huiyu Pharmaceutical (688553.SH) announced that the company recently received the company's product injection card for carfilzomib issued by the National Medical Products Administration. The injection of carfilzomib is mainly used for the treatment of multiple myeloma.

WEIYE HOLDINGS (01571) plans to change its name to "Dingjisheng International Holdings Limited"

YAN TAT GROUP (01480) plans to invest 13.8 million yuan to purchase a number of PCB processing equipment.

Accumulate high-quality development momentum, Yongda Auto's financial condition is stable, and the new energy business has become a growth engine.

WEIYE HOLDINGS (01571) plans to change its name to "Dingjisheng International Holdings Limited"

YAN TAT GROUP (01480) plans to invest 13.8 million yuan to purchase a number of PCB processing equipment.

Accumulate high-quality development momentum, Yongda Auto's financial condition is stable, and the new energy business has become a growth engine.